首页> 外国专利> AUTOLOGOUS TUMOR ORGANOID AND IMMUNE CELL CO-CULTURES AND METHODS OF USE AS PREDICTIVE MODELS FOR PANCREATIC CANCER TREATMENT

AUTOLOGOUS TUMOR ORGANOID AND IMMUNE CELL CO-CULTURES AND METHODS OF USE AS PREDICTIVE MODELS FOR PANCREATIC CANCER TREATMENT

机译:自体肿瘤有机体和免疫细胞共培养以及用作胰腺癌治疗预测模型的方法

摘要

A method for preparing an autologous pancreatic tumor organoid and immune cell co-culture is provided, including: culturing pancreatic tumor cells obtained from a patient in a culture medium to provide a pancreatic tumor organoid and an organoid-conditioned medium; pulsing dendritic cells derived from the patient with a portion of the organoid-conditioned medium; contacting the pulsed dendritic cells with cytotoxic T lymphocytes (CTLs) obtained from the patient in the organoid-conditioned medium to activate the CTLs; isolating the activated CTLs; and co-culturing the pancreatic tumor organoid with the activated CTLs and myeloid derived suppressor cells (MDSCs) derived from the patient, to obtain an autologous pancreatic tumor organoid and immune cell co-culture that mimics the patient's pancreatic tumor microenvironment. Also provided are co-cultures obtained by the disclosed methods and methods of screening and determining whether a patient is likely to benefit from a candidate therapy.
机译:提供了一种制备自体胰腺肿瘤类器官和免疫细胞共培养物的方法,包括:在培养基中培养得自患者的胰腺肿瘤细胞以提供胰腺肿瘤类器官和类器官条件培养基;用部分类器官条件培养基刺激来自患者的脉冲树突细胞;在类器官条件培养基中使脉冲树突状细胞与获自患者的细胞毒性T淋巴细胞(CTL)接触以激活CTL;隔离激活的CTL;将胰腺肿瘤类器官与患者的活化CTL和髓样来源的抑制细胞(MDSC)共同培养,以获得模仿患者胰腺肿瘤微环境的自体胰腺肿瘤类器官和免疫细胞共培养物。还提供了通过所公开的方法以及筛选和确定患者是否可能从候选疗法中受益的方法获得的共培养物。

著录项

  • 公开/公告号WO2020154579A1

    专利类型

  • 公开/公告日2020-07-30

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF CINCINNATI;

    申请/专利号WO2020US14925

  • 发明设计人 ZAVROS YANA;HOLOKAI LORYN;

    申请日2020-01-24

  • 分类号A61K35/13;A61P35;C12N5/071;C12N5/09;G01N33/50;

  • 国家 WO

  • 入库时间 2022-08-21 11:10:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号